EVENT: Agents of Change 2016
Eight-year-old Brock Gumm has been battling Osteosarcoma since October 6, 2014. Osteosarcoma is a sporadic and aggressive bone cancer that occurs primarily in children and young adults. It accounts for only 3% of all pediatric cancers, and for this reason, is not well funded for research and cures. It is unrelenting in its progression and its pain.
Brock’s long-term survival rests on his ability to receive immunotherapy treatment called Mifamurtide. It has been found in clinical trials that treatment with Mifamurtide can reduce mortality by 30 percent. It is not FDA approved in the US.
Several families in the US have now been able to get this important compound, and we believe that the Gumm family will be next. Unfortunately, this immunotherapy protocol, no matter how successful, is not covered by any insurance. To provide Brock with the very best chance at life, the Gumm family MUST raise the cost of the treatment themselves- $100,000 for the 48 vials he will need. Help us raise the necessary funds for Brock – all you have to do is CALL us today, and we will donate on your behalf!
Fullman & Lawrence Agency